Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
01-09

DJ Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ inched 0.69% higher to $74.15 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.16% to 5,918.25 and the Dow Jones Industrial Average rising 0.25% to 42,635.20.

This was the stock's second consecutive day of gains.

Edwards Lifesciences Corp. closed $21.97 short of its 52-week high ($96.12), which the company reached on March 28th.

The stock underperformed when compared to some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ rose 0.75% to $114.25, Medtronic PLC $(MDT)$ rose 3.52% to $82.68, and Stryker Corp. $(SYK)$ rose 2.51% to $364.10.

Trading volume (3.4 M) remained 1.7 million below its 50-day average volume of 5.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 08, 2025 16:56 ET (21:56 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10